PRDM2

PRDM2

Target · Histone methyltransferase

PRDM2 PR/SET domain 2 · PR domain zinc finger protein 2

PRDM2, also known as RIZ, RIZ1, RIZ2, KMT8, MTB-ZF, HUMHOXY1 and KMT8A, is a nuclear zinc finger protein with histone methyltransferase activity. It methylates histone H3 at Lys-9 and may act as a DNA-binding transcription factor. Browse Assay Genie's current range of PRDM2 research reagents below, or read on for the biology behind the target.

Nuclear proteinH3 Lys-9 methyltransferaseTumour suppressor gene
1718 aa
Protein length
~189 kDa
Molecular weight
1p36.21
Gene locus
EC 2.1.1.-
Enzyme class
Target information

What is PRDM2 (PR/SET domain 2)?

PRDM2 is an S-adenosyl-L-methionine-dependent histone methyltransferase that specifically methylates Lys-9 of histone H3. It may also function as a DNA-binding transcription factor. It binds the macrophage-specific TPA-responsive element (MTE) of the HMOX1 (heme oxygenase 1) gene and may act as a transcriptional activator of that gene. The NCBI Gene summary notes that the protein can also bind retinoblastoma protein and oestrogen receptor, and that it may be a specific effector of oestrogen action.

The PRDM2 gene encodes a zinc finger protein and belongs to a nuclear histone/protein methyltransferase superfamily. In HGNC it is classed within the C2H2-type zinc fingers, the PR/SET domain family and the putative lysine methyltransferases. UniProt places it in the class V-like SAM-binding methyltransferase superfamily. The protein is localised to the nucleus. Multiple transcript variants encoding different isoforms have been reported, which fits with the RIZ1 and RIZ2 names in the alias list. The rat ortholog is Prdm2.

NCBI describes the PRDM2 gene as a tumour suppressor gene. Its functions are not fully characterised, but it may play a role in transcriptional regulation during neuronal differentiation and in the pathogenesis of retinoblastoma. Earlier names for the gene include PR domain containing 2, with ZNF domain, and PR domain 2. Researchers studying PRDM2 work on histone H3 Lys-9 methylation, transcriptional control and oestrogen signalling. It is one of several PR domain proteins, a group that includes PRDM14.

Epigenetics and histone methylation

PRDM2 methylates Lys-9 of histone H3, making it a candidate for studies of lysine methyltransferase activity and chromatin regulation.

Tumour suppressor biology

PRDM2 is described as a tumour suppressor gene and may contribute to the pathogenesis of retinoblastoma, binding retinoblastoma protein.

Transcriptional regulation

PRDM2 may act as a DNA-binding transcription factor and as an activator of HMOX1 through the MTE element.

Estrogen signalling and neurodevelopment

PRDM2 binds oestrogen receptor and may be a specific effector of oestrogen action and of regulation during neuronal differentiation.

Background

PRDM2 frequently asked questions

What does PRDM2 do?

PRDM2 is an S-adenosyl-L-methionine-dependent histone methyltransferase that specifically methylates Lys-9 of histone H3. It may also work as a DNA-binding transcription factor, binding the MTE of the HMOX1 gene and possibly activating its transcription.

What other names and isoforms does PRDM2 have?

PRDM2 is also called RIZ, RIZ1, RIZ2, KMT8, KMT8A, MTB-ZF and HUMHOXY1. Earlier names were PR domain containing 2, with ZNF domain, and PR domain 2. NCBI reports multiple transcript variants that encode different isoforms.

Is PRDM2 linked to disease or conserved in other species?

NCBI describes the PRDM2 gene as a tumour suppressor gene that may play a role in retinoblastoma pathogenesis. Rat has an ortholog, Prdm2. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other PR/SET domain family members with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13029; product specifications from Assay Genie datasheets.

PRDM2 Product listing